Wolfe Research Upgrades Immunovant (NASDAQ: IMVT) to Outperform (correction)
Tweet Send to a Friend
(Updated - January 6, 2026 5:34 AM EST)
Wolfe Research analyst Andy Chen upgraded Immunovant (NASDAQ: IMVT) from Peerperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Wolfe Research analyst Andy Chen upgraded Immunovant (NASDAQ: IMVT) from Peerperform ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
